title: Response to letter regarding article, "incidence and clinical impact of stent fracture after everolimus-eluting stent implantation".
authors: Shoichi
authors: S
authors: Kuramitsu
authors: Masashi
authors: M
authors: Iwabuchi
authors: Takenori
authors: T
authors: Domei
authors: Makoto
authors: M
authors: Hyodo
authors: Kyohei
authors: K
authors: Yamaji
authors: Yoshimitsu
authors: Y
authors: Soga
authors: Takeshi
authors: T
authors: Arita
authors: Shinichi
authors: S
authors: Shirai
authors: Katsuhiro
authors: K
authors: Kondo
authors: Kenji
authors: K
authors: Ando
authors: Koyu
authors: K
authors: Sakai
authors: Masahiko
authors: M
authors: Goya
authors: Hiroyoshi
authors: H
authors: Yokoi
authors: Hideyuki
authors: H
authors: Nosaka
authors: Masakiyo
authors: M
authors: Nobuyoshi
authors: Takuya
authors: T
authors: Haraguchi
authors: Ayumu
authors: A
authors: Nagae
authors: Yoshitaka
authors: Y
authors: Takabatake
authors: Fumitoshi
authors: F
authors: Toyota
authors: Shinjo
authors: S
authors: Sonoda
mesh_terms: D015906:Angioplasty, Balloon, Coronary / Q000295:instrumentation*; D002317:Cardiovascular Agents / Q000008:administration & dosage*; D003324:Coronary Artery Disease / Q000628:therapy*; D054855:Drug-Eluting Stents; D005260:Female; D006801:Humans; D008297:Male; D011475:Prosthesis Failure; D020123:Sirolimus / Q000031:analogs & derivatives*
chemical_list: D002317:Cardiovascular Agents; D020123:Sirolimus